Analysis of oral anticoagulant dosing and adherence to therapy among patients with nonvalvular atrial fibrillation
JA Rymer, K Chiswell, L Young, A Chiu, L Liu… - JAMA Network …, 2023 - jamanetwork.com
Importance Although reduced doses of direct oral anticoagulants (DOACs) are approved for
patients with nonvalvular atrial fibrillation (NVAF) at high risk of bleeding, little is known …
patients with nonvalvular atrial fibrillation (NVAF) at high risk of bleeding, little is known …
Research note changes in the number of outpatient visits in Japan during the COVID-19 pandemic
M Machida, Y Nishioka, T Noda, T Imamura - BMC Research Notes, 2023 - Springer
Objective This study aimed to determine the change in the number of outpatient visits in
Japan since the beginning of the COVID-19 pandemic, using data on the outpatient claims …
Japan since the beginning of the COVID-19 pandemic, using data on the outpatient claims …
Outpatient medications associated with protection from COVID-19 hospitalization
HS Sandhu, J Lambert, Z Steckler, L Park… - PLoS …, 2023 - journals.plos.org
The COVID-19 pandemic remains the pre-eminent global health problem, and yet after more
than three years there is still no prophylactic agent against the disease aside from vaccines …
than three years there is still no prophylactic agent against the disease aside from vaccines …